NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $560 | -22.1% | 34,646 | +100.0% | 0.00% | -25.0% |
| Q2 2023 | $719 | -23.0% | 17,323 | +11.6% | 0.00% | -20.0% |
| Q1 2023 | $934 | -18.0% | 15,523 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $1,139 | -99.9% | 15,523 | +2.6% | 0.01% | -12.5% |
| Q3 2022 | $1,149,000 | +9.3% | 15,123 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $1,051,000 | -10.2% | 15,123 | +7.1% | 0.01% | 0.0% |
| Q1 2022 | $1,170,000 | -3.4% | 14,123 | -12.4% | 0.01% | +16.7% |
| Q4 2021 | $1,211,000 | -65.3% | 16,123 | +2.5% | 0.01% | -66.7% |
| Q2 2021 | $3,488,000 | +26.6% | 15,723 | -1.3% | 0.02% | +5.9% |
| Q4 2020 | $2,755,000 | – | 15,923 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |